Windlas Biotech Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Windlas Biotech Limited Reports its H1 & Q2 FY26 Financial Results".
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech Limited has informed NSE about a press release dated November 06, 2025, titled 'Windlas Biotech Limited Reports its H1 & Q2 FY26 Financial Results.' The filing itself is an intimation to the exchange and does not contain the actual financial numbers. Investors would need to refer to the linked press release or the company's investor relations page for the detailed H1 (first half) and Q2 (second quarter) results for fiscal year 2026, including revenue, profit, margins, and segment performance.
This is a routine intimation of an earnings release, not a new business development. The actual stock impact will depend on whether the reported numbers beat, match, or miss market expectations once the full results are reviewed.